Shares of health-care companies were more or less flat amid uncertainty on the outlook for insurance markets. Shares of Sucampo Pharmaceuticals rose after specialty pharmaceutical maker Mallinckrodt agreed to buy the maker of specialty medicines for constipation-related and other conditions for about $840 million.
Continue Reading Below
-Rob Curran, email@example.com
(END) Dow Jones Newswires
December 26, 2017 16:39 ET (21:39 GMT)